CVS confirms closure of clinical trial unit by the end of 2024

CVS is shutting down its Clinical Trial Service (CTS) business venture, a CVS spokesperson confirmed to Clinical Trials Arena.

In an email response, the spokesperson confirmed that CVS is evaluating its asset portfolio to ensure long-term strategic priorities. As such, CTS will wind down in a phased way, with a full exit expected by 31 December 2024.